NCT07080554

Brief Summary

Sarcopenia is one of the main problems in the elderly population. However, its diagnostic criteria have not yet been studied in two specific populations, namely institutionalized older adults in nursing homes vs community-dwelling older adults. So this will be the objective of the study. An observational study is being conducted to analyze how these diagnostic criteria relate to each other and to find possible associations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
415

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

June 28, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
Last Updated

August 8, 2025

Status Verified

July 1, 2025

Enrollment Period

2.1 years

First QC Date

June 28, 2025

Last Update Submit

August 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hand grip strenght

    The researchers used the JAMAR dynamometer

    Once at the baseline

Secondary Outcomes (3)

  • Muscular mass / appendicular skeletal mass (ASM)

    Once at the baseline

  • Physical performance

    Once at the baseline

  • Physical performance 2

    Once at the baseline

Study Arms (2)

This group includes institutionalized older adults aged 60 and over.

This group includes community-dwelling older adults aged 60 and over.

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will include two groups: one group of institutionalized older adults in nursing homes with clinical sospicius of sarcopenia and another group of community-dwelling older adults apparently healthy.

You may qualify if:

  • older adults who have been institutionalized for at least one year
  • older adults who are institutionalized with clinical suspicion of sarcopenia according to the Sarc-F questionnaire and muscle strength criteria
  • older adults residing in the community of Extrema

You may not qualify if:

  • present cognitive impairment (score \<24 Mini-Mental State Examination)
  • primary, serious, or chronic diseases that could explain the decrease in muscle strength and the other diagnostic variables of the participants
  • diseases or physical disorders that hinder the assessment of the participants; -use of drugs that may affect muscle strength and mass \[35\].

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Extremadura

Badajoz, Badajoz, 06006, Spain

Location

Study Officials

  • Luis Espejo-Antunez

    University of Extremadura

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical professor

Study Record Dates

First Submitted

June 28, 2025

First Posted

July 23, 2025

Study Start

January 1, 2022

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

August 8, 2025

Record last verified: 2025-07

Locations